Early Enteral Nutrition (via nasogastric or nasojejunal tube)
Treatment for Pancreatitis
Typical Dosage: gradually advanced, 25-50 mL/hour initial
Effectiveness
80%
Safety Score
85%
Clinical Trials
250
Participants
20K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
85
DangerousModerateSafe
Treatment Details
Dosage Range
gradually advanced, 25-50 mL/hour initial
Time to Effect
days
Treatment Duration
days to weeks
Evidence Quality
HIGHNumber Needed to Treat (NNT)
7(Treat 7 patients to see 1 additional successful outcome)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$1,000
Side Effect Mgmt:$100
Total Annual:$1,600
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
0.8
Outcome-Based Costs
Cost per Responder
$2,133.33
Comparison vs Total Parenteral Nutrition (TPN)
Cost Difference
$-5,000/year
Less expensive
QALY Difference
+0.30 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Early Enteral Nutrition (via nasogastric or nasojejunal tube) Outcomes
for Pancreatitis
Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+75%
Common Side Effects
Diarrhea
+15%
Abdominal distension
+7%
Tube displacement
+7%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov